Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass

Active Project Grant Awarded Last action

Award ID
R44HD094414
Recipient
Awarding agency
Obligated
$7,221,896

Award facts

Completion date 91% complete
Originally
Place of performance
San Francisco, CA 94105, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $991,379
Amendment $991,379
Amendment $995,592
Amendment $0
Amendment $0
Amendment $999,580
Amendment $999,580
Amendment $0
Amendment $0
Amendment $232,127
Amendment $0
Amendment $681,601
Amendment $12,990
Amendment -$12,990
Amendment $0
Amendment $1,032,262
Original award $298,396
Show all 20

Subawards

Subrecipient Amount Awarded
The Regents Of The University Of California. San Francisco UCSF investigators will test the efficacy of OMX in a model of CPB-induced myocardial dysfunction. $1,750,509

Quick answers

Who received award R44HD094414?

R44HD094414 was awarded to Omniox Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2017.

How much is award R44HD094414 worth?

$7,221,896 has been obligated on R44HD094414.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award